| Product Code: ETC7555780 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of transdermal drug delivery systems to India in 2024 continued to see strong growth, with top exporting countries being Germany, Singapore, Sri Lanka, Spain, and even India itself. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, while the compound annual growth rate (CAGR) from 2020 to 2024 stood at 3.95%, showcasing steady expansion. Notably, the growth rate from 2023 to 2024 accelerated to 4.29%, signaling increasing demand and opportunities in the Indian market for transdermal drug delivery systems.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Transdermal Drug Delivery Systems Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Transdermal Drug Delivery Systems Market Revenues & Volume, 2021 & 2031F |
3.3 India Transdermal Drug Delivery Systems Market - Industry Life Cycle |
3.4 India Transdermal Drug Delivery Systems Market - Porter's Five Forces |
3.5 India Transdermal Drug Delivery Systems Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Transdermal Drug Delivery Systems Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Transdermal Drug Delivery Systems Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in India leading to higher demand for efficient drug delivery systems |
4.2.2 Growing awareness and acceptance of transdermal drug delivery systems due to their convenience and non-invasive nature |
4.2.3 Technological advancements in transdermal delivery systems enhancing drug efficacy and patient compliance |
4.3 Market Restraints |
4.3.1 Limited availability and accessibility of advanced transdermal drug delivery technologies in certain regions of India |
4.3.2 Strict regulatory requirements and lengthy approval processes for new transdermal drug delivery products |
4.3.3 Competition from alternative drug delivery methods such as oral medications and injections |
5 India Transdermal Drug Delivery Systems Market Trends |
6 India Transdermal Drug Delivery Systems Market, By Types |
6.1 India Transdermal Drug Delivery Systems Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Transdermal Drug Delivery Systems Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 India Transdermal Drug Delivery Systems Market Revenues & Volume, By Electroporation, 2021- 2031F |
6.1.4 India Transdermal Drug Delivery Systems Market Revenues & Volume, By Radio Frequency, 2021- 2031F |
6.1.5 India Transdermal Drug Delivery Systems Market Revenues & Volume, By Iontophoresis, 2021- 2031F |
6.1.6 India Transdermal Drug Delivery Systems Market Revenues & Volume, By Microporation, 2021- 2031F |
6.1.7 India Transdermal Drug Delivery Systems Market Revenues & Volume, By Thermal, 2021- 2031F |
6.1.8 India Transdermal Drug Delivery Systems Market Revenues & Volume, By Mechanical arrays, 2021- 2031F |
6.1.9 India Transdermal Drug Delivery Systems Market Revenues & Volume, By Others, 2021- 2031F |
6.1.10 India Transdermal Drug Delivery Systems Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Transdermal Drug Delivery Systems Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India Transdermal Drug Delivery Systems Market Revenues & Volume, By CNS, 2021- 2031F |
6.2.3 India Transdermal Drug Delivery Systems Market Revenues & Volume, By Pain Management, 2021- 2031F |
6.2.4 India Transdermal Drug Delivery Systems Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.2.5 India Transdermal Drug Delivery Systems Market Revenues & Volume, By Hormone, 2021- 2031F |
6.2.6 India Transdermal Drug Delivery Systems Market Revenues & Volume, By Immunological, 2021- 2031F |
6.2.7 India Transdermal Drug Delivery Systems Market Revenues & Volume, By Metabolic, 2021- 2031F |
6.2.8 India Transdermal Drug Delivery Systems Market Revenues & Volume, By Infection, 2021- 2031F |
6.2.9 India Transdermal Drug Delivery Systems Market Revenues & Volume, By Infection, 2021- 2031F |
7 India Transdermal Drug Delivery Systems Market Import-Export Trade Statistics |
7.1 India Transdermal Drug Delivery Systems Market Export to Major Countries |
7.2 India Transdermal Drug Delivery Systems Market Imports from Major Countries |
8 India Transdermal Drug Delivery Systems Market Key Performance Indicators |
8.1 Adoption rate of transdermal drug delivery systems by healthcare providers and patients in India |
8.2 Number of research and development initiatives focused on enhancing transdermal drug delivery technologies |
8.3 Patient satisfaction and compliance rates with transdermal drug delivery systems |
8.4 Rate of market penetration of transdermal drug delivery systems in different therapeutic areas |
8.5 Number of partnerships and collaborations between pharmaceutical companies and technology providers for transdermal drug delivery systems |
9 India Transdermal Drug Delivery Systems Market - Opportunity Assessment |
9.1 India Transdermal Drug Delivery Systems Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Transdermal Drug Delivery Systems Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Transdermal Drug Delivery Systems Market - Competitive Landscape |
10.1 India Transdermal Drug Delivery Systems Market Revenue Share, By Companies, 2024 |
10.2 India Transdermal Drug Delivery Systems Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here